Clinical trial · Observational
Genotoxicity Assessment for Patients Undergoing Radiation Treatment
Genotoxicity Assessment for Patients Receiving Large Field Irradiation
NCT00167427CI-TRIAL-00074794completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the research study is to evaluate an automated, laser-based technique for measuring DNA damage caused by radiation during cancer treatment in immature red blood cells.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Measure the Change in MN-RET in the blood
- timeFrame
- Baseline and 1 day
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients that are scheduled to begin radiotherapy to the large-field chest region are eligible if: * Daily radiation dose is between 1.8 and 5 Gy/day * Any single dimension of field size is ≥ 15 cm * Provision of written informed consent or * Or patients receiving IMRT or Tomotherapy, when low-dose radiation is spread out to the normal tissues, irrespective of daily radiation doses. * Or patients receiving radionucleotides as part of the medical treatment (cancer or non-malignant conditions) * Or patients who will receive diagnostic CT scans, PET/CT scans, mammograms, or diagnostic imaging requiring radionucleotides
References
Publications (0)
Data not yet available
No reference posted for this study.